nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Vasoconstriction—Saquinavir—acquired immunodeficiency syndrome	0.0679	0.125	CcSEcCtD
Terlipressin—Vasoconstriction peripheral—Saquinavir—acquired immunodeficiency syndrome	0.0679	0.125	CcSEcCtD
Terlipressin—AVPR1B—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0152	0.0361	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0118	0.028	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0105	0.025	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0105	0.0248	CbGpPWpGaD
Terlipressin—Torsade de pointes—Nelfinavir—acquired immunodeficiency syndrome	0.009	0.0166	CcSEcCtD
Terlipressin—AVPR1B—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0085	0.0202	CbGpPWpGaD
Terlipressin—Pregnancy—Efavirenz—acquired immunodeficiency syndrome	0.00847	0.0156	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00819	0.0194	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00813	0.0193	CbGpPWpGaD
Terlipressin—Abdominal cramps—Zidovudine—acquired immunodeficiency syndrome	0.0081	0.0149	CcSEcCtD
Terlipressin—AVPR1B—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00799	0.0189	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00792	0.0188	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00716	0.017	CbGpPWpGaD
Terlipressin—Pregnancy—Lamivudine—acquired immunodeficiency syndrome	0.00688	0.0127	CcSEcCtD
Terlipressin—Abdominal cramps—Delavirdine—acquired immunodeficiency syndrome	0.00681	0.0125	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00647	0.0153	CbGpPWpGaD
Terlipressin—AVPR1A—lung—acquired immunodeficiency syndrome	0.00645	0.181	CbGeAlD
Terlipressin—Respiratory failure—Stavudine—acquired immunodeficiency syndrome	0.00641	0.0118	CcSEcCtD
Terlipressin—Respiratory failure—Abacavir—acquired immunodeficiency syndrome	0.00631	0.0116	CcSEcCtD
Terlipressin—Skin exfoliation—Nevirapine—acquired immunodeficiency syndrome	0.00622	0.0115	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00603	0.0143	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00589	0.014	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00585	0.0139	CbGpPWpGaD
Terlipressin—Torsade de pointes—Saquinavir—acquired immunodeficiency syndrome	0.00583	0.0108	CcSEcCtD
Terlipressin—Abdominal cramps—Lamivudine—acquired immunodeficiency syndrome	0.00578	0.0107	CcSEcCtD
Terlipressin—Cyanosis—Saquinavir—acquired immunodeficiency syndrome	0.00578	0.0107	CcSEcCtD
Terlipressin—AVPR1A—central nervous system—acquired immunodeficiency syndrome	0.00575	0.162	CbGeAlD
Terlipressin—Pallor—Delavirdine—acquired immunodeficiency syndrome	0.00554	0.0102	CcSEcCtD
Terlipressin—AVPR1A—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00554	0.0131	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0055	0.013	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00549	0.013	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00548	0.013	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00545	0.0129	CbGpPWpGaD
Terlipressin—AVPR2—lung—acquired immunodeficiency syndrome	0.00534	0.15	CbGeAlD
Terlipressin—Respiratory failure—Indinavir—acquired immunodeficiency syndrome	0.00518	0.00954	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00496	0.0118	CbGpPWpGaD
Terlipressin—AVPR2—nervous system—acquired immunodeficiency syndrome	0.00495	0.139	CbGeAlD
Terlipressin—AVPR2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00492	0.0117	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0048	0.0114	CbGpPWpGaD
Terlipressin—AVPR2—central nervous system—acquired immunodeficiency syndrome	0.00476	0.134	CbGeAlD
Terlipressin—Skin exfoliation—Efavirenz—acquired immunodeficiency syndrome	0.00459	0.00845	CcSEcCtD
Terlipressin—AVPR1A—brain—acquired immunodeficiency syndrome	0.00456	0.128	CbGeAlD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00449	0.0106	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00445	0.0106	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00442	0.0105	CbGpPWpGaD
Terlipressin—Skin exfoliation—Delavirdine—acquired immunodeficiency syndrome	0.00439	0.00809	CcSEcCtD
Terlipressin—Acute coronary syndrome—Amprenavir—acquired immunodeficiency syndrome	0.00438	0.00808	CcSEcCtD
Terlipressin—Myocardial infarction—Amprenavir—acquired immunodeficiency syndrome	0.00436	0.00803	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00434	0.0103	CbGpPWpGaD
Terlipressin—Respiratory failure—Ritonavir—acquired immunodeficiency syndrome	0.00433	0.00798	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00418	0.00991	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00415	0.00984	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.004	0.00948	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.0038	0.009	CbGpPWpGaD
Terlipressin—AVPR2—brain—acquired immunodeficiency syndrome	0.00378	0.106	CbGeAlD
Terlipressin—AVPR2—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00377	0.00894	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00376	0.00891	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00376	0.00891	CbGpPWpGaD
Terlipressin—Hot flush—Efavirenz—acquired immunodeficiency syndrome	0.00373	0.00687	CcSEcCtD
Terlipressin—Cardiac disorder—Amprenavir—acquired immunodeficiency syndrome	0.0037	0.00683	CcSEcCtD
Terlipressin—Menopausal symptoms—Efavirenz—acquired immunodeficiency syndrome	0.0037	0.00681	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00366	0.00866	CbGpPWpGaD
Terlipressin—Malnutrition—Amprenavir—acquired immunodeficiency syndrome	0.00347	0.0064	CcSEcCtD
Terlipressin—Cardiac failure—Delavirdine—acquired immunodeficiency syndrome	0.00342	0.0063	CcSEcCtD
Terlipressin—Acute coronary syndrome—Abacavir—acquired immunodeficiency syndrome	0.00342	0.0063	CcSEcCtD
Terlipressin—Myocardial infarction—Abacavir—acquired immunodeficiency syndrome	0.0034	0.00626	CcSEcCtD
Terlipressin—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00335	0.00617	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00333	0.00789	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00331	0.00784	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0033	0.00783	CbGpPWpGaD
Terlipressin—Hot flush—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00585	CcSEcCtD
Terlipressin—Menopausal symptoms—Saquinavir—acquired immunodeficiency syndrome	0.00315	0.0058	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00313	0.00742	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0031	0.00734	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00306	0.00726	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00304	0.00721	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00301	0.00713	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00299	0.00708	CbGpPWpGaD
Terlipressin—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.00298	0.0055	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00297	0.00703	CbGpPWpGaD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00294	0.00698	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.00294	0.00541	CcSEcCtD
Terlipressin—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.00287	0.0053	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00286	0.00678	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Indinavir—acquired immunodeficiency syndrome	0.0028	0.00517	CcSEcCtD
Terlipressin—Myocardial infarction—Indinavir—acquired immunodeficiency syndrome	0.00279	0.00514	CcSEcCtD
Terlipressin—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00278	0.00513	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00277	0.00657	CbGpPWpGaD
Terlipressin—Malnutrition—Nelfinavir—acquired immunodeficiency syndrome	0.00276	0.00508	CcSEcCtD
Terlipressin—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.00275	0.00508	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00275	0.00652	CbGpPWpGaD
Terlipressin—Malnutrition—Stavudine—acquired immunodeficiency syndrome	0.00275	0.00507	CcSEcCtD
Terlipressin—Malnutrition—Abacavir—acquired immunodeficiency syndrome	0.00271	0.00499	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00268	0.00636	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00261	0.00618	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00261	0.00618	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00259	0.00613	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00259	0.00613	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00258	0.00611	CbGpPWpGaD
Terlipressin—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.00255	0.0047	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00253	0.00601	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00252	0.00598	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00252	0.00598	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00252	0.00596	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00245	0.00451	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.00241	0.00444	CcSEcCtD
Terlipressin—Malnutrition—Zidovudine—acquired immunodeficiency syndrome	0.00239	0.0044	CcSEcCtD
Terlipressin—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.00235	0.00433	CcSEcCtD
Terlipressin—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.00234	0.00432	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00233	0.0043	CcSEcCtD
Terlipressin—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.00233	0.0043	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00232	0.00428	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00229	0.00543	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.00229	0.00422	CcSEcCtD
Terlipressin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00228	0.0042	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00227	0.00539	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00226	0.00535	CbGpPWpGaD
Terlipressin—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.00226	0.00416	CcSEcCtD
Terlipressin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00224	0.00413	CcSEcCtD
Terlipressin—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.00224	0.00413	CcSEcCtD
Terlipressin—Malnutrition—Indinavir—acquired immunodeficiency syndrome	0.00222	0.0041	CcSEcCtD
Terlipressin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.0022	0.00406	CcSEcCtD
Terlipressin—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00219	0.00403	CcSEcCtD
Terlipressin—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00219	0.00403	CcSEcCtD
Terlipressin—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.00218	0.00402	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00217	0.00514	CbGpPWpGaD
Terlipressin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00217	0.004	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00215	0.00511	CbGpPWpGaD
Terlipressin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00215	0.00396	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00215	0.00509	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00213	0.00505	CbGpPWpGaD
Terlipressin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.0021	0.00387	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00206	0.00487	CbGpPWpGaD
Terlipressin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00204	0.00377	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00204	0.00484	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00204	0.00484	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00204	0.00484	CbGpPWpGaD
Terlipressin—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00203	0.00375	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00203	0.0048	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00202	0.00372	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00202	0.00478	CbGpPWpGaD
Terlipressin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.00201	0.0037	CcSEcCtD
Terlipressin—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00201	0.0037	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00201	0.0037	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00198	0.0047	CbGpPWpGaD
Terlipressin—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.00365	CcSEcCtD
Terlipressin—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00197	0.00363	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00197	0.00466	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00194	0.00358	CcSEcCtD
Terlipressin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00194	0.00358	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00194	0.00357	CcSEcCtD
Terlipressin—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.00357	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00192	0.00455	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00192	0.00455	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00192	0.00455	CbGpPWpGaD
Terlipressin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00191	0.00353	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00191	0.00352	CcSEcCtD
Terlipressin—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00191	0.00351	CcSEcCtD
Terlipressin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00189	0.00349	CcSEcCtD
Terlipressin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00189	0.00349	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00188	0.00346	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00188	0.00445	CbGpPWpGaD
Terlipressin—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00344	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00186	0.00441	CbGpPWpGaD
Terlipressin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.00186	0.00342	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00185	0.00437	CbGpPWpGaD
Terlipressin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00184	0.00339	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00183	0.00434	CbGpPWpGaD
Terlipressin—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00181	0.00334	CcSEcCtD
Terlipressin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0018	0.00332	CcSEcCtD
Terlipressin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00179	0.0033	CcSEcCtD
Terlipressin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.0033	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00179	0.00423	CbGpPWpGaD
Terlipressin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00178	0.00328	CcSEcCtD
Terlipressin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00178	0.00328	CcSEcCtD
Terlipressin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00178	0.00327	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.00327	CcSEcCtD
Terlipressin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00177	0.00327	CcSEcCtD
Terlipressin—AVPR2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00177	0.0042	CbGpPWpGaD
Terlipressin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00177	0.00326	CcSEcCtD
Terlipressin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00176	0.00325	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00175	0.00414	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00175	0.00414	CbGpPWpGaD
Terlipressin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00175	0.00322	CcSEcCtD
Terlipressin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00174	0.00321	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00174	0.00411	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00174	0.00411	CbGpPWpGaD
Terlipressin—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00173	0.0032	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00173	0.0041	CbGpPWpGaD
Terlipressin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00171	0.00315	CcSEcCtD
Terlipressin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.00314	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0017	0.00402	CbGpPWpGaD
Terlipressin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Terlipressin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Terlipressin—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00308	CcSEcCtD
Terlipressin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.00307	CcSEcCtD
Terlipressin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00164	0.00303	CcSEcCtD
Terlipressin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00162	0.00298	CcSEcCtD
Terlipressin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00162	0.00298	CcSEcCtD
Terlipressin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00296	CcSEcCtD
Terlipressin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.00295	CcSEcCtD
Terlipressin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00294	CcSEcCtD
Terlipressin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00159	0.00293	CcSEcCtD
Terlipressin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00158	0.00292	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.0029	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00157	0.00289	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00157	0.00371	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00155	0.00368	CbGpPWpGaD
Terlipressin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00285	CcSEcCtD
Terlipressin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00284	CcSEcCtD
Terlipressin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00284	CcSEcCtD
Terlipressin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00154	0.00283	CcSEcCtD
Terlipressin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00154	0.00283	CcSEcCtD
Terlipressin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Terlipressin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.00281	CcSEcCtD
Terlipressin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00151	0.00279	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00279	CcSEcCtD
Terlipressin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.00274	CcSEcCtD
Terlipressin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00273	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00273	CcSEcCtD
Terlipressin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Terlipressin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00271	CcSEcCtD
Terlipressin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00269	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00146	0.00346	CbGpPWpGaD
Terlipressin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00146	0.00268	CcSEcCtD
Terlipressin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00268	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.00266	CcSEcCtD
Terlipressin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Terlipressin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Terlipressin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Terlipressin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00263	CcSEcCtD
Terlipressin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00261	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00261	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00142	0.00336	CbGpPWpGaD
Terlipressin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00141	0.0026	CcSEcCtD
Terlipressin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00141	0.00259	CcSEcCtD
Terlipressin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00141	0.00259	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00141	0.00333	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0014	0.00331	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00139	0.00329	CbGpPWpGaD
Terlipressin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00138	0.00255	CcSEcCtD
Terlipressin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00138	0.00254	CcSEcCtD
Terlipressin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00252	CcSEcCtD
Terlipressin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.0025	CcSEcCtD
Terlipressin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Terlipressin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Terlipressin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00134	0.00246	CcSEcCtD
Terlipressin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00246	CcSEcCtD
Terlipressin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00133	0.00246	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00133	0.00315	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00133	0.00315	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00133	0.00315	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00132	0.00313	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00132	0.00313	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00132	0.00313	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00132	0.00312	CbGpPWpGaD
Terlipressin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00242	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00241	CcSEcCtD
Terlipressin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.0013	0.0024	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0013	0.00308	CbGpPWpGaD
Terlipressin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00239	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00129	0.00306	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00127	0.003	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00126	0.00298	CbGpPWpGaD
Terlipressin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00229	CcSEcCtD
Terlipressin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00229	CcSEcCtD
Terlipressin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00229	CcSEcCtD
Terlipressin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00122	0.00225	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00222	CcSEcCtD
Terlipressin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00221	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0012	0.00284	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00119	0.00282	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00118	0.00279	CbGpPWpGaD
Terlipressin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00216	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00117	0.00277	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00116	0.00275	CbGpPWpGaD
Terlipressin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.00214	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00115	0.00274	CbGpPWpGaD
Terlipressin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00213	CcSEcCtD
Terlipressin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00213	CcSEcCtD
Terlipressin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00114	0.00209	CcSEcCtD
Terlipressin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00207	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00111	0.00263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00111	0.00263	CbGpPWpGaD
Terlipressin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00203	CcSEcCtD
Terlipressin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00201	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00109	0.00257	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00109	0.00257	CbGpPWpGaD
Terlipressin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00199	CcSEcCtD
Terlipressin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00198	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00105	0.00248	CbGpPWpGaD
Terlipressin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00192	CcSEcCtD
Terlipressin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Terlipressin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00189	CcSEcCtD
Terlipressin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00188	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00101	0.0024	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00101	0.00238	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.001	0.00238	CbGpPWpGaD
Terlipressin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000999	0.00184	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000985	0.00234	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000985	0.00234	CbGpPWpGaD
Terlipressin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000974	0.0018	CcSEcCtD
Terlipressin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000964	0.00178	CcSEcCtD
Terlipressin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000953	0.00176	CcSEcCtD
Terlipressin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00095	0.00175	CcSEcCtD
Terlipressin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000928	0.00171	CcSEcCtD
Terlipressin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000914	0.00169	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000912	0.00216	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000906	0.00215	CbGpPWpGaD
Terlipressin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000901	0.00166	CcSEcCtD
Terlipressin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000885	0.00163	CcSEcCtD
Terlipressin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000872	0.00161	CcSEcCtD
Terlipressin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000867	0.0016	CcSEcCtD
Terlipressin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000827	0.00152	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000825	0.00196	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000813	0.00193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000803	0.0019	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.0008	0.0019	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000797	0.00189	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000794	0.00188	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000793	0.00188	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000768	0.00182	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000768	0.00182	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000763	0.00181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000763	0.00181	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000752	0.00178	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000752	0.00178	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00075	0.00178	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000747	0.00177	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000747	0.00177	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000744	0.00176	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000738	0.00175	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000726	0.00172	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000721	0.00171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000695	0.00165	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00069	0.00163	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000685	0.00162	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000683	0.00162	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000683	0.00162	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000678	0.00161	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000678	0.00161	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000675	0.0016	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000619	0.00147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000582	0.00138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000582	0.00138	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000572	0.00136	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000568	0.00135	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000564	0.00134	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00056	0.00133	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000549	0.0013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00052	0.00123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000516	0.00122	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000515	0.00122	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000512	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000512	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000508	0.0012	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000499	0.00118	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000474	0.00112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000471	0.00112	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000468	0.00111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000465	0.0011	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000443	0.00105	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000436	0.00103	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00043	0.00102	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000429	0.00102	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000426	0.00101	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000403	0.000956	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000403	0.000956	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000401	0.000949	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000401	0.000949	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000399	0.000946	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00039	0.000925	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000307	0.000728	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000305	0.000722	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000302	0.000717	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.0003	0.000712	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000298	0.000706	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000296	0.000701	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000277	0.000655	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000275	0.000651	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00027	0.000641	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000269	0.000636	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000231	0.000546	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000229	0.000544	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00016	0.000379	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000159	0.000377	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000159	0.000376	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000158	0.000374	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000135	0.000321	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.39e-05	0.000223	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.32e-05	0.000221	CbGpPWpGaD
